What is the current stock price of PRISM BioLab Co.,LTD (206A.T)?

As of the latest market data, PRISM BioLab Co.,LTD (206A.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does PRISM BioLab Co.,LTD (206A.T) pay a dividend?

Based on current data, PRISM BioLab Co.,LTD does not have a confirmed active dividend policy.

What is the market cap of PRISM BioLab Co.,LTD?

The current market capitalization of PRISM BioLab Co.,LTD (206A.T) is approximately unavailable.

206A.T

PRISM BioLab Co.,LTD·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2024-07-02

Beta

1.01

Websitewww.prismbiolab.com↗